Soluble vascular endothelial growth factor receptors 2 (sVEGFR-2) and 3 (sVEGFR-3) and breast cancer risk in the Swedish Mammography Cohort

about

Pro- and antiangiogenic VEGF and its receptor status for the severity of diabetic retinopathy.

P2860

Q33828636-0FD3C3E9-0381-4042-B8E4-230E6998B67E

P2860

Soluble vascular endothelial growth factor receptors 2 (sVEGFR-2) and 3 (sVEGFR-3) and breast cancer risk in the Swedish Mammography Cohort

Item

http://www.wikidata.org/entity/Q36874976

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Soluble vascular endothelial g ...... the Swedish Mammography Cohort

@en

type

Item

label

Soluble vascular endothelial g ...... the Swedish Mammography Cohort

@en

prefLabel

Soluble vascular endothelial g ...... the Swedish Mammography Cohort

@en

P1476

Soluble vascular endothelial g ...... the Swedish Mammography Cohort

@en

P2093

Holly Harris

http://www.w3.org/2001/XMLSchema#string

Marie-Paule Vasson

http://www.w3.org/2001/XMLSchema#string

Samar Basu

http://www.w3.org/2001/XMLSchema#string

P2860

Vascular endothelial growth factor (VEGF) upregulates BCL-2 and inhibits apoptosis in human and murine mammary adenocarcinoma cells

Vascular endothelial growth factor receptor-2 in breast cancer.

VEGF-C-VEGFR3/Flt4 axis regulates mammary tumor growth and metastasis in an autocrine manner.

Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3

Integrin (alpha 6 beta 4) regulation of eIF-4E activity and VEGF translation: a survival mechanism for carcinoma cells

Production of VEGF and expression of the VEGF receptors Flt-1 and KDR in primary cultures of epithelial and stromal cells derived from breast tumours.

The association between vascular endothelial growth factor expression in invasive breast cancer and survival varies with intrinsic subtypes and use of adjuvant systemic therapy: results from the Nurses' Health Study

Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy.

Long-term fatty fish consumption and renal cell carcinoma incidence in women.

Vascular endothelial growth factor is a strong predictor of early distant recurrences in a prospective study of premenopausal women with lymph-node negative breast cancer.

P304

81-86

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Alicja Wolk

Anders Larsson

P577

2016-03-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27186332

http://www.w3.org/2001/XMLSchema#string

P921

endothelium

P932

4858620

http://www.w3.org/2001/XMLSchema#string

Soluble vascular endothelial growth factor receptors 2 (sVEGFR-2) and 3 (sVEGFR-3) and breast cancer risk in the Swedish Mammography Cohort

about

P2860

P2860

Soluble vascular endothelial growth factor receptors 2 (sVEGFR-2) and 3 (sVEGFR-3) and breast cancer risk in the Swedish Mammography Cohort

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P50

P577

P698

P921

P932

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P50

P577

P698

P921

P932